BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 32373999)

  • 1. Coronavirus disease 2019: a clinical review.
    Yang CL; Qiu X; Zeng YK; Jiang M; Fan HR; Zhang ZM
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4585-4596. PubMed ID: 32373999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update on the status of COVID-19: a comprehensive review.
    Zhao N; Zhou ZL; Wu L; Zhang XD; Han SB; Bao HJ; Shu Y; Shu XG
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4597-4606. PubMed ID: 32374000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The viral, epidemiologic, clinical characteristics and potential therapy options for COVID-19: a review.
    Li C; Xu BH
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4576-4584. PubMed ID: 32373998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19: a conundrum to decipher.
    Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
    Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
    Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development.
    Alturki SO; Alturki SO; Connors J; Cusimano G; Kutzler MA; Izmirly AM; Haddad EK
    Front Immunol; 2020; 11():1880. PubMed ID: 32973779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in SARS-CoV-2: a systematic review.
    Bai YX; Xu YH; Wang X; Sun C; Guo Y; Qiu S; Ma KW
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):9208-9215. PubMed ID: 32965016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 from the Perspective of a Gastroenterologist.
    Boo SJ
    Korean J Gastroenterol; 2020 Jul; 76(1):4-8. PubMed ID: 32703914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of a Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2: Biology and Therapeutic Options.
    Khan S; Siddique R; Shereen MA; Ali A; Liu J; Bai Q; Bashir N; Xue M
    J Clin Microbiol; 2020 Apr; 58(5):. PubMed ID: 32161092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review.
    Liya G; Yuguang W; Jian L; Huaiping Y; Xue H; Jianwei H; Jiaju M; Youran L; Chen M; Yiqing J
    APMIS; 2020 Jun; 128(6):423-432. PubMed ID: 32363707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a newly emerged pathogen: an overview.
    Rathore JS; Ghosh C
    Pathog Dis; 2020 Aug; 78(6):. PubMed ID: 32840560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Parkinsonism: Is There Evidence for Concern?
    Monje MHG; Martínez-Fernández R
    Mov Disord; 2020 Oct; 35(10):1725. PubMed ID: 33068472
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future].
    Ye ZW; Jin DY
    Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):571-592. PubMed ID: 32347053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response.
    Astuti I; Ysrafil
    Diabetes Metab Syndr; 2020; 14(4):407-412. PubMed ID: 32335367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential pathogenesis of severe acute respiratory syndrome coronavirus 2.
    Wu T; Zhang H; Hu E; Ma J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):591-597. PubMed ID: 32879112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focus on the Crosstalk between COVID-19 and Urogenital Systems.
    Wu ZS; Zhang ZQ; Wu S
    J Urol; 2020 Jul; 204(1):7-8. PubMed ID: 32249664
    [No Abstract]   [Full Text] [Related]  

  • 17. Natural Flavonoids as Potential Angiotensin-Converting Enzyme 2 Inhibitors for Anti-SARS-CoV-2.
    Muchtaridi M; Fauzi M; Khairul Ikram NK; Mohd Gazzali A; Wahab HA
    Molecules; 2020 Sep; 25(17):. PubMed ID: 32882868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.
    Guo YR; Cao QD; Hong ZS; Tan YY; Chen SD; Jin HJ; Tan KS; Wang DY; Yan Y
    Mil Med Res; 2020 Mar; 7(1):11. PubMed ID: 32169119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infectivity of human coronavirus in the brain.
    Cheng Q; Yang Y; Gao J
    EBioMedicine; 2020 Jun; 56():102799. PubMed ID: 32474399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical lymphocyte morphology in SARS-CoV-2 infection.
    El Jamal SM; Salib C; Stock A; Uriarte-Haparnas NI; Glicksberg BS; Teruya-Feldstein J; Dembitzer FR; Nadkarni GN; Firpo-Betancourt A
    Pathol Res Pract; 2020 Sep; 216(9):153063. PubMed ID: 32825937
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.